相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan
Fu-Chih Hsiao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
Renal safety and efficacy of angiotensin receptor-neprilysin inhibitor: A meta-analysis of randomized controlled trials
Yu Feng et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
Sacubitril/valsartan vs. angiotensin receptor inhibition in heart failure: a real-world study in Taiwan
Po-Cheng Chang et al.
ESC HEART FAILURE (2020)
Long-Term Effects of Angiotensin Receptor-Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
Gregor Poglajen et al.
DIAGNOSTICS (2020)
Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: A meta-analysis
Huaning Kang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials
Francesco Spannella et al.
ESC HEART FAILURE (2020)
Efficacy and Safety Outcome of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) in Patients with Heart Failure and Preserved Ejection Fraction (HFpEF): Preliminary Results
Fayez Elshaer et al.
RESEARCH REPORTS IN CLINICAL CARDIOLOGY (2020)
Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction A retrospective cohort study
R. De Vecchis et al.
HERZ (2019)
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
Javad Habibi et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction
Eugenio Roberto Cosentino et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
Francesco Spannella et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology
Stefano Bianchi et al.
JOURNAL OF NEPHROLOGY (2019)
Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view
Borja Quiroga et al.
NEFROLOGIA (2019)
Are We Barking Up the Wrong Tree? Rise in Serum Creatinine and Heart Failure
Amir Kazory et al.
BLOOD PURIFICATION (2019)
Evolution of functional class,biochemical and echocardiographic parameters and clinical outcomes after sacubitril/valsartan initiation in daily practice
Herminio Morillas-Climent et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2019)
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Akshay S. Desai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
Jens van de Wouw et al.
FRONTIERS IN PHYSIOLOGY (2019)
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation PRIME Study
Duk-Hyun Kang et al.
CIRCULATION (2019)
Sacubitril/Valsartan in Daily Clinical Practice: Data From a Prospective Registry
Lourdes Vicent et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction
David Montero et al.
PHYSIOLOGICAL REPORTS (2019)
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Kevin Damman et al.
JACC-HEART FAILURE (2018)
Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality
Julio Nunez et al.
CIRCULATION (2018)
Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
Ramesh R. Dargad et al.
INDIAN HEART JOURNAL (2018)
Prevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor
Kentaro Ushijima et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction A Meta-Analysis of Published Study Data
Iris E. Beldhuis et al.
CIRCULATION-HEART FAILURE (2017)
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Scott A. Hubers et al.
CIRCULATION (2016)
Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation
Jozine M. ter Maaten et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Hyperkalemia in Heart Failure
Chaudhry M. S. Sarwar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Pathophysiology of Heart Failure
Edit Tanai et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Heart Failure Pathophysiology, Diagnosis, Medical Treatment Guidelines, and Nursing Management
Chad Rogers et al.
NURSING CLINICS OF NORTH AMERICA (2015)
Neprilysin inhibition in chronic kidney disease
Parminder Judge et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
The pathophysiology of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure
Orly Vardeny et al.
JACC-HEART FAILURE (2014)
Hypertensive Heart Disease and Obesity: A Complex Interaction Between Hemodynamic and Not Hemodynamic Factors
Riccardo Sarzani et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2014)
Renal Function and Heart Failure Treatment When Is a Loss Really a Gain?
Marvin A. Konstam
CIRCULATION-HEART FAILURE (2011)
Transient and sustained increases in glomerular permeability following ANP infusion in rats
Josefin Axelsson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
Jessie Gu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Molecular biology of the natriuretic peptide system - Implications for physiology and hypertension
David G. Gardner et al.
HYPERTENSION (2007)
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure
HL Hillege et al.
CIRCULATION (2006)
Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions
LR Potter et al.
ENDOCRINE REVIEWS (2006)
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists
M Azizi et al.
CIRCULATION (2004)
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
LF Fried et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Atrial natriuretic peptide-induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patients
G Vervoort et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
